BDS' current core technologies in the marketplace are:
> DR CALUX^® for dioxins and dioxin-like compounds such as PCBs;
> ER CALUX^® for estrogens and pseudo estrogens;
> AR CALUX^® androgen hormones.

For new assays and developments contact us


BioDetection Systems offers its CALUX^® technology in two principle ways:
1.  Licensing of CALUX^® technology for use in-house or to offer to third parties;
2.  Contract analytical CALUX^® work including ISO17025 analysis

Contact us to discuss your requirements


We also provide related and other services including:
> Consultancy
> New and novel receptor based bioassays
> Reference materials
> Others

See other services for more details